Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma

J Am Acad Dermatol. 2021 Dec;85(6):1610-1611. doi: 10.1016/j.jaad.2020.11.067. Epub 2020 Dec 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects*
  • Carcinoma, Transitional Cell / drug therapy*
  • Drug Eruptions / etiology*
  • Humans
  • Lymphatic Metastasis
  • Skin / drug effects*
  • Skin / pathology
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / secondary

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological
  • enfortumab vedotin